# STOCKHOLM 1.0
#=GF ID   SepSecS
#=GF AC   PF05889.17
#=GF DE   O-phosphoseryl-tRNA(Sec) selenium transferase, SepSecS
#=GF PI   SLA_LP_auto_ag;
#=GF AU   Moxon SJ;0000-0003-4644-1816
#=GF SE   Pfam-B_9614 (release 8.0)
#=GF GA   21.10 21.10;
#=GF TC   21.10 21.10;
#=GF NC   21.00 21.00;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -E 1000 --cpu 4 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0061
#=GF RN   [1]
#=GF RM   10801173
#=GF RT   Identification of target antigen for SLA/LP autoantibodies in
#=GF RT   autoimmune hepatitis. 
#=GF RA   Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum
#=GF RA   Buschenfelde KH, Lohse AW; 
#=GF RL   Lancet 2000;355:1510-1515.
#=GF RN   [2]
#=GF RM   11481605
#=GF RT   A bioinformatical approach suggests the function of the
#=GF RT   autoimmune hepatitis target antigen soluble liver antigen/liver
#=GF RT   pancreas. 
#=GF RA   Kernebeck T, Lohse AW, Grotzinger J; 
#=GF RL   Hepatology 2001;34:230-233.
#=GF RN   [3]
#=GF RM   17194211
#=GF RT   Biosynthesis of selenocysteine on its tRNA in eukaryotes.
#=GF RA   Xu XM, Carlson BA, Mix H, Zhang Y, Saira K, Glass RS, Berry MJ,
#=GF RA   Gladyshev VN, Hatfield DL;
#=GF RL   PLoS Biol. 2007;5:e4.
#=GF RN   [4]
#=GF RM   17512006
#=GF RT   Structural insights into the second step of RNA-dependent
#=GF RT   cysteine biosynthesis in archaea: crystal structure of
#=GF RT   Sep-tRNA:Cys-tRNA synthase from Archaeoglobus fulgidus.
#=GF RA   Fukunaga R, Yokoyama S;
#=GF RL   J Mol Biol. 2007;370:128-141.
#=GF RN   [5]
#=GF RM   18093968
#=GF RT   Structure and catalytic mechanism of eukaryotic selenocysteine
#=GF RT   synthase.
#=GF RA   Ganichkin OM, Xu XM, Carlson BA, Mix H, Hatfield DL, Gladyshev
#=GF RA   VN, Wahl MC;
#=GF RL   J Biol Chem. 2008;283:5849-5865.
#=GF RN   [6]
#=GF RM   18158303
#=GF RT   Structural insights into RNA-dependent eukaryal and archaeal
#=GF RT   selenocysteine formation.
#=GF RA   Araiso Y, Palioura S, Ishitani R, Sherrer RL, O'Donoghue P, Yuan
#=GF RA   J, Oshikane H, Domae N, Defranco J, Soll D, Nureki O;
#=GF RL   Nucleic Acids Res. 2008;36:1187-1199.
#=GF RN   [7]
#=GF RM   19608919
#=GF RT   The human SepSecS-tRNASec complex reveals the mechanism of
#=GF RT   selenocysteine formation.
#=GF RA   Palioura S, Sherrer RL, Steitz TA, Soll D, Simonovic M;
#=GF RL   Science. 2009;325:321-325.
#=GF DR   INTERPRO; IPR008829;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   Early annotation suggested this family, SepSecS, of several
#=GF CC   eukaryotic and archaeal proteins, was involved in
#=GF CC   antigen-antibodies responses in the liver and pancreas [1,2].
#=GF CC   Structural studies show that the family is
#=GF CC   O-phosphoseryl-tRNA(Sec) selenium transferase, an enzyme
#=GF CC   involved in the synthesis of the amino acid selenocysteine
#=GF CC   (Sec). Sec is the only amino acid whose biosynthesis occurs on
#=GF CC   its cognate transfer RNA (tRNA). SepSecS catalyses the final
#=GF CC   step in the formation of the amino acid [3,4,5,6].  The early
#=GF CC   observation that autoantibodies isolated from patients with type
#=GF CC   I autoimmune hepatitis targeted a ribonucleoprotein complex
#=GF CC   containing tRNASec led to the identification and
#=GF CC   characterisation of the archaeal and the human SepSecS [2].
#=GF CC   SepSecS forms its own branch in the family of fold-type I
#=GF CC   pyridoxal phosphate (PLP) enzymes that goes back to the last
#=GF CC   universal common ancestor which explains why the archaeal
#=GF CC   sequences Swiss:Q8TXK0 and Swiss:Q8TYR3 are annotated as being
#=GF CC   pyridoxal phosphate-dependent enzymes.
#=GF SQ   5
#=GS SPSS1_ARCFU/33-368  AC O30207.1
#=GS SPCS_CAEEL/53-450   AC Q18953.1
#=GS SPCS_HUMAN/61-459   AC Q9HD40.2
#=GS SPCS_METJA/57-434   AC Q58027.1
#=GS SPCS_METKA/53-429   AC Q8TXK0.1
SPSS1_ARCFU/33-368             GDGYSVCDFCTTGR.......LDEIKTPPIHDFIHN..........QLPKFLGCDV.ARVTN..........GAREAK..FAV.................MHSLAKKDAWVVMDENCHYSSYVAAERAGLNIALVPKTDYPDYAITPENFAQTIEETKKRGEVVLALITYPDGNYGNLPD.VKKIAKVCSEYDVPLLVNGAYAI...............GRMPVSLKEIGADFIVGSGHKSMAASGPIGVMGMKEEWAEIVLRRSEKYKNKEVELLGCTARGATIITLMASFPHVRERIKRWDEEVEKARRFAAEMEKLGIKQLGDNPHNHDLMFFHAEVLYEISKKAKGGRFFLYRELKSRKIHGIK......PGLT..................RYFKL.STYGLSDEEVDYVLNAFKEIIE
SPCS_CAEEL/53-450              HDTNNRVDMIPVGAGEREGRVLTPLVQRLHSNLTHGIGRSGNLLEIQ.PKALGSSMLACLSNEFAKHALHLLGLHAVKSCIVVPLCTGMSLSLCMTSWRRRRPKAKYVVWLRIDQK...SSLKSIYHAGFEPIIVEPIRDRDSLITDVETVNRII.EQRGEE.ILCVMTTTSCFAPRSPDNVEAISAICAAHDVPHLVNNAYGLQSEETIRKIAAAHECGRVDAVVQSLDKNFQVPVGGAVIAAFKQNHIQSIAQSYPGRASSVPSRDLVLTLLYQGQSAFLEPFGKQKQMFLKMRRKLISFAENIG..............ECVYEVPENEISSAMTLSTIPPAKQ......TLFGSILFAKGITGARVVTSSQSKTTIEGCEFINFGSHTTEQHGGYLNIACSVGMTDHELEELFTRLTSSYA
SPCS_HUMAN/61-459              MDSNNFLG..NCGVGEREGRVASALVARRHYRFIHGIGRSGDISAVQ.PKAAGSSLLNKITNSLVLDIIKLAGVHTVANCFVVPMATGMSLTLCFLTLRHKRPKAKYIIWPRIDQK...SCFKSMITAGFEPVVIENVLEGDELRTDLKAVEAKV.QELGPDCILCIHSTTSCFAPRVPDRLEELAVICANYDIPHIVNNAYGVQSSKCMHLIQQGARVGRIDAFVQSLDKNFMVPVGGAIIAGFNDSFIQEISKMYPGRASASPSLDVLITLLSLGSNGYKKLLKERKEMFSYLSNQIKKLSEAYN..............ERLLHTPHNPISLAMTLKTLDEHRD...KAVTQLGSMLFTRQVSGAR.VVPLGSMQTVSGYTFRGFMSHTNNYPCAYLNAASAIGMKMQDVDLFIKRLDRCLK
SPCS_METJA/57-434              MDTDKDPN..VVQIGEREARVYTKLQRDGVFDFCHGVGRSGNLIDPQ.PKAPGASVMYKLTNKLLESFLKALGLK..VNAIATPVATGMSLALCLSAAR.KKYNSNVVIYPYAAHK...SPIKATSFIGMRMRLVETVLDGDIVKVEVSDIEDAIRKEINENNNPVVLSTLTFFPPRKSDDIKEIAKICQDYDIPHIINGAYAIQNFYYIEKLKKALKY.RIDAVVSSSDKNLFTPIGGGIIYTKDESFLKEISLTYPGRASANPIVNILISLLAIGTKDYLNLMKEQKECKKLLNELLEDLAKKKG..............EKVLNV.ENPISSCITTK..........KDPLDVAGKLYNLRVTGPRGVRRNDKFGT..........CYLKEYPYDYIVVNSAIGVKKEDIYKVIEKLDEVL.
SPCS_METKA/53-429              MDTDKDPK..AARIGEREARVASRLAEESVFGFCHGVGRSGTLVDPQ.PKAPGASIMYALTNRLVTDFLRRLGFR.IEGAFVVPGATGLSIALCLSALG....EGEEVIYPYAAHK...SPIKAVRLAGFGMRVVDTEIEGDRIVVDPGDVEEAL.ER..SESPAAVLSTLTFFPPRSSDPLPEIAELCEEYGVPHVVNAAYGIQHEQYRDLLNRAIKRGRVDVVVSSTDKNLLTPVGGGIVYAPDEETLREVSRAYPGRASAAPVAHALISLLSLGMKGYRRLMRRQKECKALLDELLEDLEARRD..............DVRVLDVDNPIASAVAVEGHDP.........VDLAARLYVRRVTGPRGVRADDPFGT..........SRLRGYHSNYITINAAIGVREEDVKTAVERLERELE
#=GC seq_cons                  MDTsscsc..ssGlGEREuRVhocLspcslacFsHGlGRSGsLl-sQ.PKAsGuSlhs+LTNcLlpchL+hLGl+tlcssFVVPhATGMSLuLChouhR.++scAKhVIWPhhDcK...SslKAsppAGFchtlVEsll-GDpllTDlssVEctl.cchssEslLsVlSTsosFsPRsPDslcEIAcICu-YDVPHlVNuAYGIQspphhchlppAh+hGRlDAVVpSlDKNFhVPVGGuIIAAhc-salpEIScsYPGRASAsPstclLIoLLuLGssuYtcLh+cQKEsFshLcEpLccLuEchs..............EpllcsP-NPISSAhTlcsls.hpp...ts.spLuucLasR+VTGsRsVpsssshsT..........S+hppY.ssYlslsSAIGl+-EDV-pllcRL-csLc
